ALIGN TECHNOLOGY, INC. Selling and Marketing Expense
ALIGN TECHNOLOGY, INC. (ALGN) reported Selling and Marketing Expense of $1.07 billion for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2020-02-28
- ALIGN TECHNOLOGY, INC. selling and marketing expense for the quarter ending 2015-12-31 was $99.58M, a 15.94% increase year-over-year.
- ALIGN TECHNOLOGY, INC. selling and marketing expense for the quarter ending 2015-09-30 was $101.75M, a 26.16% increase year-over-year.
- ALIGN TECHNOLOGY, INC. selling and marketing expense for the quarter ending 2015-06-30 was $100.63M, a 20.57% increase year-over-year.
- ALIGN TECHNOLOGY, INC. selling and marketing expense for the quarter ending 2015-03-31 was $88.28M, a 7.57% increase year-over-year.
- ALIGN TECHNOLOGY, INC. selling and marketing expense for fiscal 2019 was $1.07B, a 25.77% increase from fiscal 2018.
- ALIGN TECHNOLOGY, INC. selling and marketing expense for fiscal 2018 was $852.40M, a 28.03% increase from fiscal 2017.
- ALIGN TECHNOLOGY, INC. selling and marketing expense for fiscal 2017 was $665.78M, a 35.69% increase from fiscal 2016.
- ALIGN TECHNOLOGY, INC. selling and marketing expense for fiscal 2016 was $490.65M, a 25.73% increase from fiscal 2015.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $1.07B 10-K · filed 2020-02-28 | |||||||
| 2018-12-31 | $852.40M 10-K · filed 2020-02-28 | |||||||
| 2017-12-31 | $665.78M 10-K · filed 2020-02-28 | |||||||
| 2016-12-31 | $490.65M 10-K · filed 2019-02-28 | |||||||
| 2015-12-31 | $99.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $201.33M derived: sum of 2 quarters · filed 2018-02-28 | $301.96M derived: sum of 3 quarters · filed 2018-02-28 | $390.24M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $101.75M 10-Q · filed 2015-10-29 | $202.38M derived: sum of 2 quarters · filed 2015-10-29 | $290.66M 10-Q · filed 2015-10-29 | $376.55M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $100.63M 10-Q · filed 2015-07-30 | $188.91M 10-Q · filed 2015-07-30 | $274.80M derived: sum of 3 quarters · filed 2017-02-28 | $355.45M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $88.28M 10-Q · filed 2015-05-01 | $174.17M derived: sum of 2 quarters · filed 2017-02-28 | $254.83M derived: sum of 3 quarters · filed 2017-02-28 | $338.28M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $85.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $166.55M derived: sum of 2 quarters · filed 2017-02-28 | $250.00M derived: sum of 3 quarters · filed 2017-02-28 | $332.07M 10-K · filed 2017-02-28 | $217.26M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $80.65M 10-Q · filed 2015-10-29 | $52.37M 10-Q · filed 2014-10-30 | $164.11M derived: sum of 2 quarters · filed 2015-10-29 | $246.18M 10-Q · filed 2015-10-29 | $161.64M 10-Q · filed 2014-10-30 | $290.87M derived: sum of 4 quarters · filed 2015-10-29 | ||
| 2014-06-30 | $83.45M 10-Q · filed 2015-07-30 | $56.39M 10-Q · filed 2014-07-31 | $165.52M 10-Q · filed 2015-07-30 | $109.27M 10-Q · filed 2014-07-31 | $210.22M derived: sum of 3 quarters · filed 2015-07-30 | $255.44M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2014-03-31 | $82.07M 10-Q · filed 2015-05-01 | $52.89M 10-Q · filed 2014-05-01 | $126.76M derived: sum of 2 quarters · filed 2015-05-01 | $171.99M derived: sum of 3 quarters · filed 2015-05-01 | $219.83M derived: sum of 4 quarters · filed 2015-05-01 | |||
| 2013-12-31 | $44.69M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $89.92M derived: sum of 2 quarters · filed 2015-02-26 | $137.76M derived: sum of 3 quarters · filed 2015-02-26 | $180.05M 10-K · filed 2015-02-26 | ||||
| 2013-09-30 | $45.22M 10-Q · filed 2014-10-30 | $93.07M derived: sum of 2 quarters · filed 2014-10-30 | $135.35M 10-Q · filed 2014-10-30 | $173.12M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $47.85M 10-Q · filed 2014-07-31 | $90.13M 10-Q · filed 2014-07-31 | $127.90M derived: sum of 3 quarters · filed 2015-02-26 | $164.37M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $42.28M 10-Q · filed 2014-05-01 | $80.05M derived: sum of 2 quarters · filed 2015-02-26 | $116.52M derived: sum of 3 quarters · filed 2015-02-26 | $155.60M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $37.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $74.24M derived: sum of 2 quarters · filed 2015-02-26 | $113.32M derived: sum of 3 quarters · filed 2015-02-26 | $152.04M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $36.47M 10-Q · filed 2013-11-01 | $75.56M derived: sum of 2 quarters · filed 2013-11-01 | $114.27M 10-Q · filed 2013-11-01 | $150.38M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $39.09M 10-Q · filed 2013-08-02 | $77.80M 10-Q · filed 2013-08-02 | $113.92M derived: sum of 3 quarters · filed 2014-02-28 | $148.57M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $38.72M 10-Q · filed 2013-05-03 | $74.83M derived: sum of 2 quarters · filed 2014-02-28 | $109.48M derived: sum of 3 quarters · filed 2014-02-28 | $148.07M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $36.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $70.77M derived: sum of 2 quarters · filed 2014-02-28 | $109.35M derived: sum of 3 quarters · filed 2014-02-28 | $142.17M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $34.66M 10-Q · filed 2012-11-09 | $73.24M derived: sum of 2 quarters · filed 2012-11-09 | $106.06M 10-Q · filed 2012-11-09 | $136.28M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $38.59M 10-Q · filed 2012-08-02 | $71.41M 10-Q · filed 2012-08-02 | $101.63M derived: sum of 3 quarters · filed 2013-03-01 | $128.53M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $32.82M 10-Q · filed 2012-05-08 | $63.04M derived: sum of 2 quarters · filed 2013-03-01 | $89.95M derived: sum of 3 quarters · filed 2013-03-01 | $118.89M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $30.22M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $57.13M derived: sum of 2 quarters · filed 2013-03-01 | $86.07M derived: sum of 3 quarters · filed 2013-03-01 | $114.01M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $26.91M 10-Q · filed 2011-11-04 | $55.84M derived: sum of 2 quarters · filed 2011-11-04 | $83.79M 10-Q · filed 2011-11-04 | $111.68M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $28.94M 10-Q · filed 2011-08-08 | $56.88M 10-Q · filed 2011-08-08 | $84.78M derived: sum of 3 quarters · filed 2012-02-29 | $112.47M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $27.95M 10-Q · filed 2011-05-05 | $55.84M derived: sum of 2 quarters · filed 2012-02-29 | $83.53M derived: sum of 3 quarters · filed 2012-02-29 | $112.63M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $27.89M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $55.58M derived: sum of 2 quarters · filed 2012-02-29 | $84.69M derived: sum of 3 quarters · filed 2012-02-29 | $112.54M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $27.69M 10-Q · filed 2010-11-04 | $56.80M derived: sum of 2 quarters · filed 2010-11-04 | $84.65M 10-Q · filed 2010-11-04 | |||||
| 2009-06-30 | $29.11M 10-Q · filed 2010-08-05 | $56.96M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | $115.06M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |